Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126938172 | 12693817 | 2 | F | 20160912 | 20160829 | 20160922 | PER | US-009507513-1608USA011732 | MERCK | 0.00 | M | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126938172 | 12693817 | 1 | PS | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | UNK | D | 22044 | FILM-COATED TABLET | ||||||||
126938172 | 12693817 | 2 | SS | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | Oral | UNK | D | 22044 | FILM-COATED TABLET | ||||||||
126938172 | 12693817 | 3 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126938172 | 12693817 | 1 | Type 2 diabetes mellitus |
126938172 | 12693817 | 3 | Type 2 diabetes mellitus |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126938172 | 12693817 | Asthenia | |
126938172 | 12693817 | Diarrhoea | |
126938172 | 12693817 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126938172 | 12693817 | 1 | 201604 | 0 | ||
126938172 | 12693817 | 2 | 2016 | 0 | ||
126938172 | 12693817 | 3 | 201604 | 0 |